<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02506569</url>
  </required_header>
  <id_info>
    <org_study_id>TA109</org_study_id>
    <nct_id>NCT02506569</nct_id>
  </id_info>
  <brief_title>ProMRI 3T ENHANCED Master Study</brief_title>
  <official_title>ProMRI 3T ENHANCED Master Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation is designed to provide supporting evidence for the clinical safety of the
      Biotronik's new Implantable Cardioverter Defibrillator systems when used under specific 3
      Tesla MR conditions .
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">January 15, 2018</completion_date>
  <primary_completion_date type="Actual">January 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serious Adverse Device Effect (SADE)-free rate of implantable cardioverter defibrillators and leads possibly or securely related to the MRI procedure</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in pacing thresholds ratios measured between 1-month post-MRI and pre-MRI</measure>
    <time_frame>1 Month</time_frame>
    <description>Evaluate the percentage of ICD leads with an increase in the pacing threshold ratio measured between the Pre-MRI and 1-month post-MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decrease in sensing amplitude ratios between 1-month post-MRI and pre-MRI</measure>
    <time_frame>1 Month</time_frame>
    <description>Evaluate the percentage of ICD leads with a decrease in the sensing amplitude ratio measured between the Pre-MRI and 1-month post-MRI</description>
  </primary_outcome>
  <enrollment type="Actual">129</enrollment>
  <condition>Safety of MR (Magnetic Resonance)-Conditional ICDs</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantable Cardioverter Defibrillator therapy</intervention_name>
    <description>Tachycardia Fast Heart Beat</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>MRI scan of the head and lower body parts</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients selected for participation should be from the investigator's general patient
        population according to the inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implanted with Implantable Cardioverter Defibrillator (ICD) system according to
             Clinical Investigational Plan (CIP)

          -  ICD system was implanted in the pectoral region

          -  Implantation at least 5 weeks prior to enrollment date

          -  Patient body height ≥ 140 cm

          -  Age ≥ 18 years

          -  Right Ventricular pacing threshold (at 0.4 ms) measurable and ≤ 2.0 V

          -  Written informed consent

          -  Able and willing to complete MRI testing

          -  Able and willing to complete all testing required by the clinical protocol

          -  Available for all follow-up visits at the investigational site

        Exclusion Criteria:

          -  Standard contraindication for MRI scans

          -  Patient shows signs of a twiddler's syndrome, i.e. fiddles with implant

          -  Explantation, exchange or reposition of ICD or lead within 5 weeks prior to enrollment
             date

          -  Charging status of the battery is Elective Replacement Indicator (ERI) or End of
             Service (EOS)

          -  MRI scan within 5 weeks prior to enrollment date

          -  R-wave sensing amplitude &lt; 6.5 millivolt

          -  Lead impedance less than 200 or greater than 1500 Ohm

          -  Life expectancy of less than six months

          -  Cardiac surgery in the next six months

          -  Pregnant or breastfeeding

          -  Participation in another interventional clinical investigation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rainer Zbinden, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Triemli Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Linz</name>
      <address>
        <city>Linz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landesklinikum St. Pölten</name>
      <address>
        <city>St. Pölten</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Göttingen</name>
      <address>
        <city>Göttingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Bonifatius Hospital</name>
      <address>
        <city>Lingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Heart Centre</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtspital Triemli</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Germany</country>
    <country>Singapore</country>
    <country>Switzerland</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2015</study_first_submitted>
  <study_first_submitted_qc>July 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2015</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

